Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2025-12-24 @ 12:37 PM
NCT ID:
NCT01441661
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed, unresectable advanced renal cell carcinoma;
* Sunitinib as first-line treatment alone or combined with other therapies.
Exclusion Criteria:
* History of Grade 3/4 severe allergic reaction to Sunitinib or its metabolites
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01441661
Study Brief:
Protocol Section:
NCT01441661